Tom Daschle, the former Senate Majority Leader and a senior, informal, advisor to President Obama during the health debate has been writing and talking about how the law got passed. In his new book, “Getting It Done,” Daschle talks about the challenges facing the administration now, including walking the line between the “pragmatic and idealistic” and…
Due in large part to the investments made in biomedical research, advancements in treating, detecting, and preventing cancer are evolving at a rapid rate. The wealth of information generated through research is being translated into new methods of selecting the right treatments for the right patients at the right time. This includes examining patients’ genetic…
Due in large part to the investments made in biomedical research, advancements in treating, detecting, and preventing cancer are evolving at a rapid rate. The wealth of information generated through research is being translated into new methods of selecting the right treatments for the right patients at the right time. This includes examining patients’ genetic…
Due in large part to the investments made in biomedical research, advancements in treating, detecting, and preventing cancer are evolving at a rapid rate. The wealth of information generated through research is being translated into new methods of selecting the right treatments for the right patients at the right time. This includes examining patients’ genetic…
By Lewis Krauskopf, UnitedHealth Group Inc (UNH.N) is trying to change how it reimburses oncologists using a method the insurer says could improve treatment practices. The U.S. health insurer has started a pilot program involving five physician practices across the country, focusing on breast, colon and lung cancers, the company announced on Wednesday. Oncologists currently…
By Lewis Krauskopf, UnitedHealth Group Inc (UNH.N) is trying to change how it reimburses oncologists using a method the insurer says could improve treatment practices. The U.S. health insurer has started a pilot program involving five physician practices across the country, focusing on breast, colon and lung cancers, the company announced on Wednesday. Oncologists currently…
By Lewis Krauskopf, UnitedHealth Group Inc (UNH.N) is trying to change how it reimburses oncologists using a method the insurer says could improve treatment practices. The U.S. health insurer has started a pilot program involving five physician practices across the country, focusing on breast, colon and lung cancers, the company announced on Wednesday. Oncologists currently…
Less than two months before the FDA is set to make a politically charged decision on the use of Genentech Inc.’s best-selling cancer drug, Avastin, in breast cancer patients, a potentially influential voice has weighed in in favor of the drug. To a point. The National Comprehensive Cancer Network — a not-for-profit alliance of 21…
Less than two months before the FDA is set to make a politically charged decision on the use of Genentech Inc.’s best-selling cancer drug, Avastin, in breast cancer patients, a potentially influential voice has weighed in in favor of the drug. To a point. The National Comprehensive Cancer Network — a not-for-profit alliance of 21…
Less than two months before the FDA is set to make a politically charged decision on the use of Genentech Inc.’s best-selling cancer drug, Avastin, in breast cancer patients, a potentially influential voice has weighed in in favor of the drug. To a point. The National Comprehensive Cancer Network — a not-for-profit alliance of 21…
